. Author manuscript; available in PMC: 2019 Jun 1.

Published in final edited form as: Gynecol Oncol. 2018 Apr 2;149(3):484–490. doi: 10.1016/j.ygyno.2018.03.054

Table 2.

Number of women who completed PRO measures

PRO measure	Preoperative (54 eligible women) n (%)	Postoperative		Number of women who completed PRO measures at all time points
PRO measure	Preoperative (54 eligible women) n (%)	6 months (41 eligible women) n (%)	1 year (37 eligible women) n (%)
SWD	N/A	28 (68.3)	28 (75.7)	22
Investigator-designed exenteration instrument	N/A	33 (80.5)	33 (89.2)	26
Stoma-QOL	n/a	31 (75.6)	27 (73.0)	20
SAQ	42 (77.7)	N/A	34 (91.9)	27
BIS	43 (79.6)	33 (80.5)	34 (91.9)	22
DUFSS	39 (72.2)	32 (78.0)	34 (91.9)	20
CES-D	43 (79.6)	33 (80.5)	34 (91.9)	22
SF-12	43 (79.6)	32 (78.0)	34 (91.9)	22
MDASI	43 (79.6)	34 (82.9)	34 (91.9)	23

N/A = Not applicable (PRO measure was not collected at time point)